D-0306-2021 Class III Terminated
FDA drug recall D-0306-2021 was initiated by Edge Pharma, LLC on Feb 17, 2021 and is designated Class III. Reason for recall: Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions The recall status is terminated (terminated Jun 10, 2021). Affected quantity: 213 kits.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 24, 2021
- Initiation Date
- Feb 17, 2021
- Termination Date
- Jun 10, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 213 kits
Product description
Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe, Edge Pharma, LLC, 856 Hercules Dr., Dolchester, VT 06448 NDC # 05446-1600-05
Reason for recall
Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions
Distribution pattern
Nationwide in the US
Code information
Lot # 12-2020-16@10, BUD 3-30-21 Lot # 11-2020-18@11, BUD 3-02-21
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0306-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026